Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II studyV Georgoulias, N Androulakis, A M Dimopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative GroupD Mavroudis, N Malamos, A Alexopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2019
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) projectJ Souglakos, I Boukovinas, S Kakolyris, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II studyV Georgoulias, N Androulakis, A M Dimopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative GroupD Mavroudis, N Malamos, A Alexopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2019
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) projectJ Souglakos, I Boukovinas, S Kakolyris, et al.
Pageof 13